Trial Profile
Multinational phase I/II trial of CJC 1134 in patients with stable type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 19 Feb 2010
Price :
$35
*
At a glance
- Drugs Albenatide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 05 Apr 2007 New trial record.